(Total Views: 306)
Posted On: 06/15/2021 10:20:48 AM
Post# of 59

$NURO News Article - NeuroMetrix Reports that Quell Technology is to be Evaluated for Neuromyelitis Optica Spectrum Disorder (NMOSD) in a Randomized Controlled Trial https://marketwirenews.com/news-releases/neur...80107.html


My Twitter: WhyteStocks